POTELIGEO Mechanism of Action
7:30
POTELIGEO and the CCR4 Target
16:26
The POTELIGEO Infusion Process
20:46
Subtypes of CTCL: Mycosis Fungoides and Sézary Syndrome (Full Interview)
2:10
TN Alpha Inhibitors in Rheumatoid Arthritis
11:41
EXPERT PERSPECTIVES: Patient Monitoring & Adherence
8:07
Jim's Journey: Sézary Syndrome (patient)
5:24
Drug Development: Mogamulizumab
8:03